| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |